Andy Goren
Prof. Andy Goren has over 25 years of experience in research, development, and commercialization of breakthrough therapeutics and diagnostics. Among the list of many firsts in dermatology, Prof. Goren was the first to develop a clinical genetic test for predicting androgenetic alopecia, the first to discover epigenetic markers predicting anti-androgen therapy response in female androgenetic alopecia, the first to develop a clinical acne vulgaris antibiotic response test based on
##MORE## P. Acnes bacterial genomics, and the first to develop a rapid test for predicting minoxidil response in androgenetic alopecia. Prof. Goren was involved in the development, commercialization, and listing of several drugs and medical devices including new therapies for female pattern hair loss, chemotherapy-induced alopecia, excessive hair shedding, female sexual dysfunction, and COVID-19. His latest research is focused on human adaptation to the energy crisis. Prof. Goren currently serves as an External Medical Advisor and a Co-Researcher at the Trichology Unit, Ramon y Cajal Hospital, Madrid, Spain; a Visiting Professor of Dermatology at the Department of Dermatology and Venereology, Clinical Hospital Center Sestre Milosrdnice, Zagreb, Croatia; a Medical Doctor at the Skin & Cosmetic Research Dept., Shanghai Skin Disease Hospital, Shanghai, China; and a Visiting Medical Doctor at the Department of Dermatology and Venereology, L.T.M. Medical College Sion, Mumbai, India. As the Clinical Research Director at Samel Hospital, Manaus, Brazil, Prof. Goren has published dozens of peer-reviewed original medical research papers. He is an honorary as well as ordinary member of several dermatology societies worldwide as well as a regular lecturer at dermatology congresses around the world. He has had numerous appearances and interviews on TV, radio, and in prestigious newspapers.
Tülin Güleç
Prof. Dr. A. Tülin Güleç has been working as a dermatovenereologist since 1997, and has become Professor of Dermatology in 2010. She had been working in Başkent University Faculty of Medicine in Ankara for almost 24 years, and was the chair of Dermatology and Venereology Department for 7 years (2013-2020). Prof. Güleç runs her own Skin and Hair Health Clinic since October 2020. She is the member of Turkish Association of Dermatology and Venereology, European Academy of Dermatology and Venereology,
##MORE## SCOPE (Skin care in organ transplant patients Europe), International Dermoscopy Society (board member of Turkey since 2021) and International Trichoscopy Society. Her main medical fields of expertise are hair disorders and trichoscopy, skin cancers and dermoscopy, and skin diseases in organ transplant patients. Prof. Tülin Güleç has more than fifty-five international publications. She is the author of the Trichoscopy section of first Turkish Atlas of Dermatoscopy (2017), and she is the author of chapter titled “Hair in systemic diseases” in Hair Disorders. Eds. Alexander Katoulis, Dimitrios Ioannides, and Dimitris Rigopoulos. CRC Press, Taylor and Francis.
Matthew Harries
Dr Matthew Harries received his medical degree from the University of Leeds, UK (1998).During specialist dermatology training he took time out of programme to study the hair immune system in primary cicatricial alopecias. He was awarded a PhD from the University of Manchester in 2011. He now works as a Clinical Senior Lecturer at the University of Manchester and an Honorary Consultant Dermatologist at Salford Royal Hospital. He is a Fellow of the Royal College of Physicians in London.
##MORE## He is the co-lead of the NIHR Manchester BRC inflammatory hair diseases research programme, a member of the British Skin Foundation charity large grant awards committee and sits on the Alopecia UK charity research committee. He is currently leading the BAD living guidelines for management of people with alopecia areata and was the lead author for the acquired hair disorders chapter in the 10 th Edition Rook Textbook of Dermatology.